A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Eisai

Status: Not yet enrolling

Conditions: Primary Generalized Tonic-clonic Seizures; Partial-Onset Seizures

Treatments: Other: No Intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT06657378

E2007-M081-517

Details and patient eligibility

About

The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures [including secondarily generalized seizures]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).

Enrollment: 110 estimated patients

Sex: All

Ages: 4+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants with epilepsy who received the Fycompa for injection for the first time will be included.

Exclusion criteria

• The exclusion criteria will not be specified in particular because this survey will be conducted in daily clinical practice.

Trial design

110 participants in 1 patient group

Fycompa

Treatment:

Other: No Intervention